Novartis to Sell Roche Stake Without Premium

May 25, 2016


Novartis is ready to sell its $13.8 billion stake in rival Roche without demanding a premium, said CEO Joe Jimenez.

Novartis has been discussing options with banks for selling its Roche shares worth about $13.81 billion, possibly with an eye toward providing cash for new deals, according to a Reuters article.

In the past, Jiminez has said he would want a premium price for the Roche stake, but on Wednesday, he said that is no longer a dealbreaker.

Read the Reuters article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments